BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/21/2022 11:35:30 AM | Browse: 657 | Download: 1749
 |
Received |
|
2021-10-01 13:35 |
|
Peer-Review Started |
|
2021-10-01 13:37 |
|
First Decision by Editorial Office Director |
|
2021-12-10 02:00 |
|
Return for Revision |
|
2021-12-10 02:00 |
|
Revised |
|
2021-12-24 12:21 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-02-28 05:42 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-03-06 21:51 |
|
Articles in Press |
|
2022-03-06 21:51 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-04-02 00:36 |
|
Publish the Manuscript Online |
|
2022-04-21 11:35 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Observational Study |
| Article Title |
Surgery in platinum-resistant recurrent epithelial ovarian carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ling-Qin Zhao, Wen Gao, Ping Zhang, Ying-Li Zhang, Chen-Yan Fang and Hua-Feng Shou |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Medical Science Project of Zhejiang Province |
2018KY027 |
|
| Corresponding Author |
Hua-Feng Shou, MD, N/A, N/A, Department of Gynecology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, No.158 Shangtang Road, Xiacheng District,Hangzhou, Zhejiang, Zhejiang 310014, China. shouhuafeng@hmc.edu.cn |
| Key Words |
Carcinoma; Ovarian epithelial; Cisplatin; Drug resistance; Neoplasm; Surgical treatment |
| Core Tip |
This retrospective study examined 38 patients with platinum-resistant epithelial ovarian carcinoma (EOC). R0 resection was achieved in 25 (65.8%) and R1/2 in 13 (34.2%). Twenty-five (65.8%) patients required organ resection. Nine (23.7%) patients had operative complications, 36 (94.7%) received chemotherapy, and five (13.2%) had targeted therapy. Median progression-free survival (PFS) and overall survival (OS) were 10 and 28 mo, respectively; median chemotherapy-free interval (CFI) was 9 mo. R0 resection and postoperative chemotherapy significantly prolonged PFS and OS, and R0 resection also significantly prolonged CFI. Overall, these findings indicated secondary cytoreductive surgery is feasible for the treatment of platinum-resistant recurrent EOC. |
| Publish Date |
2022-04-21 11:35 |
| Citation |
Zhao LQ, Gao W, Zhang P, Zhang YL, Fang CY, Shou HF. Surgery in platinum-resistant recurrent epithelial ovarian carcinoma. World J Clin Cases 2022; 10(12): 3739-3753 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i12/3739.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i12.3739 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
